Method for producing genome-edited soybean plant in which allergens are reduced by gene editing of gm p34, gm p34h1, and gm p34h2, and allergen-reduced genome-edited soybean plant produced using method
The CRISPR/Cas9 system edits the GmP34, GmP34h1, and GmP34h2 genes in soybeans to reduce allergens, addressing the challenge of soybean allergies and enhancing soybean utilization through efficient and stable gene editing.
Patent Information
- Application Number
- PCT/KR2025/011744
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-12
- Filing Date
- 2025-08-05
- Publication Date
- 2026-11-19
AI Technical Summary
Existing methods do not effectively address the reduction of allergens in soybeans, particularly the P34 protein, which causes over 65% of soybean allergies, limiting the utilization of soybean-based foods.
Utilizing the CRISPR/Cas9 gene editing system to target and edit the GmP34, GmP34h1, and GmP34h2 genes in soybean plants, introducing guide RNA and an endonuclease protein to correct the genome and redifferentiate soybean plants, thereby reducing allergen expression.
The method efficiently and cost-effectively produces soybean plants with reduced allergens, enhancing their usability for food and feed, and ensures stable transmission to subsequent generations without external genes, thus reducing the time and cost associated with GMO evaluations.
Smart Images

Figure KR2025011744_19112026_PF_FP_ABST
Abstract
Description
A method for producing a genome-edited soybean plant with reduced allergens by editing the GmP34, GmP34h1, and GmP34h2 genes, and a genome-edited soybean plant with reduced allergens produced by the said method
[0001] The present invention relates to a method for producing a genome-edited soybean plant with reduced allergens by editing the GmP34, GmP34h1, and GmP34h2 genes, and to a genome-edited soybean plant with reduced allergens produced by the said method.
[0002]
[0003] This result was carried out with the support of the Rural Development Administration's Next Generation Crop New Breeding Technology Development Project (Project No.: RS-2024-00322277).
[0004] Soybeans (Glycine max) are rich in protein, fat, and dietary fiber, and contain various health-functional substances such as isoflavones, anthocyanins, lecithin, lutein, and saponins. Therefore, they possess high nutritional value as a food and are also a crop with significant industrial value for use in animal feed and processing. However, soybean seeds contain various proteins that cause allergies, which can lead to allergies when consuming processed soybean products such as bean sprouts, tofu, and soy milk. In particular, it is known that more than 65% of soybean allergies are attributed to the P34 protein; thus, the P34 protein is a representative antinutrient that must be removed to expand the utilization of various soybean-based foods. Accordingly, the present invention aimed to develop a technology capable of rapidly securing and cultivating soybeans with reduced allergens by simultaneously removing the P34 protein and its homologous proteins.
[0005] Meanwhile, among genome editing methods, the CRISPR / Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats / CRISPR associated protein 9) system has recently been attracting attention. Using CRISPR / Cas9 technology, a third-generation gene editing technique, it is possible to specifically edit only the desired genes within a cell in a short period of time. It has been proven to be more accurate and efficient than existing first-generation Zinc Finger Nucleases (ZFNs) and second-generation Transcriptor Activator-Like Effector Nucleases (TALENs), and it has the advantages of simple design and low cost. Furthermore, it has recently been reported that this technology has been successfully used to induce transformation in various plant species, such as tomatoes, grapes, and rice. It has also been confirmed that these mutant individuals are stably transmitted to the next generation.
[0006] The efficiency of such gene editing technology improves depending on the accuracy of locating the complementary base sequence of the target guide RNA (gRNA), and the optimal use of gRNA is an efficient tool for reducing the time, effort, and cost of various scientific studies, such as the production of genetically modified crops.
[0007] Meanwhile, Korean Published Patent No. 2024-0121188 discloses a 'genetically edited soybean plant with reduced soybean allergenicity and a method for producing the same' using guide RNA targeting the beta-conglycinin gene, and Korean Registered Patent No. 2704256 discloses a 'method for producing a soybean plant with reduced phytic acid content by editing the GmIPK1 gene and a genome-edited soybean plant with reduced phytic acid content produced by said method.' However, there is no description of the method for producing a genome-edited soybean plant with reduced allergens by editing the GmP34, GmP34h1, and GmP34h2 genes of the present invention, nor of the genome-edited soybean plant with reduced allergens produced by said method.
[0008] The present invention was derived from the above-mentioned requirements. The inventors confirmed that the allergen-edited soybean plant produced using a CRISPR / Cas9 system that simultaneously targets soybean-derived GmP34, GmP34h1, and GmP34h2 genes does not express the allergen P34 protein, and completed the present invention by confirming that 100% of the gene-edited soybean line can be secured in the T1 generation using gRNA1 and gRNA3 according to the present invention.
[0009] To solve the above problem, the present invention provides a method for producing a genome-edited soybean plant with reduced allergens, comprising: (a) a step of correcting the genome by introducing a guide RNA and an endonuclease protein specific to the target nucleotide sequences of soybean-derived GmP34, GmP34h1, and GmP34h2 genes into a soybean plant cell; and (b) a step of redifferentiating a soybean plant from the genome-edited soybean plant cell.
[0010] In addition, the present invention provides a genome-edited soybean plant with reduced allergens produced by the above method and seeds thereof.
[0011] In addition, the present invention provides a genome editing composition for reducing allergens in soybean plants, comprising as an active ingredient a recombinant vector comprising DNA encoding a guide RNA specific to the target nucleotide sequences of soybean-derived GmP34, GmP34h1, and GmP34h2 genes and a nucleic acid sequence encoding an endonuclease protein; or a complex of a guide RNA specific to the target nucleotide sequences of soybean-derived GmP34, GmP34h1, and GmP34h2 genes and an endonuclease protein.
[0012] The method for producing genome-edited plants according to the present invention is expected to save costs and time, unlike GMO crops which require enormous costs and time to evaluate safety and environmental hazards, as the plants do not have external genes inserted and possess only minor mutations indistinguishable from natural variations. Furthermore, since CRISPR gene editing technology introduces mutations in specific genes, it is expected to serve as a permanent method for enhancing quantitative traits.
[0013] In addition, since the manufacturing method of the present invention can rapidly secure soybean plants with reduced expression of the allergen P34 protein, it is expected that the usability and value of soybeans for food and feed can be enhanced.
[0014] Figure 1 shows the target location (A) and target sequence (B) of gRNA1 and gRNA3 used for gene editing of GmP34, GmP34h1 and GmP34h2 in the present invention.
[0015] Figure 2 is a schematic diagram of the pMDC123_pcoCas9_CRISPR_P34 vector used for gene editing of GmP34, GmP34h1, and GmP34h2 in the present invention.
[0016] Figure 3 shows the PCR results confirming the GmP34, GmP34h1, and GmP34h2 gene correction in T0 transformants with GmP34, GmP34h2, and GmP34h2 genes corrected. W82: Wild-type soybean plant.
[0017] Figure 4 shows the results of comparing the nucleotide sequences of the GmP34, GmP34h1, and GmP34h2 genes of T0 transformants (#1, #14) in which the GmP34, GmP34h1, and GmP34h2 genes were corrected with those of wild-type soybean plants to confirm whether there was a substitution or deletion of nucleotides.
[0018] Figure 5 shows the Western blot results confirming the expression of P34 protein in T1 transformants (#1, #14) with the GmP34, GmP34h1, and GmP34h2 genes edited. W82: Wild-type soybean plant.
[0019] Figure 6 shows the results of confirming 100% gene-edited homozygotes through PCR analysis confirming the GmP34, GmP34h1, and GmP34h2 gene editing in T1 transformants (#1, #14) in which the GmP34, GmP34h1, and GmP34h2 genes were edited using gRNA1 and gRNA3. Bar: Marker gene, W82: Wild-type soybean plant.
[0020] Figure 7 shows the results of comparing the nucleotide sequences of the GmP34, GmP34h1, and GmP34h2 genes of T1 transgenic plants (#1, #14) in which the GmP34, GmP34h1, and GmP34h2 genes were corrected with those of wild-type soybean plants to confirm whether there was a substitution or deletion of nucleotides.
[0021] Figure 8 shows the target sites of gRNA1 and gRNA2 used for GmP34 and GmP34h1 gene editing (A), and the results of confirming 100% gene-edited homozygotes through PCR analysis confirming whether GmP34 and GmP34h1 genes were edited in T3 transformants (B). Bar: Marker gene, W82: Wild-type soybean plant.
[0022] Figure 9 shows the results of confirming heterozygotes through PCR analysis to verify the GmP34 and GmP34h1 gene correction in T1 transformants in which the GmP34 and GmP34h1 genes were corrected using gRNA1 and gRNA2. W82: Wild-type soybean plant.
[0023] To achieve the objective of the present invention, the present invention comprises the steps of: (a) correcting the genome by introducing a guide RNA and an endonuclease protein specific to the target nucleotide sequences of soybean-derived GmP34, GmP34h1, and GmP34h2 genes into soybean plant cells; and
[0024] (b) a step of redifferentiating a soybean plant from a soybean plant cell with the above-mentioned genome edited; the present invention provides a method for producing a genome-edited soybean plant with reduced allergens, comprising: (b) a step of redifferentiating a soybean plant from a soybean plant cell with the above-mentioned genome edited.
[0025] In the method for producing a genome-edited soybean plant with reduced allergens according to the present invention, the allergen may preferably be P34 protein, and more preferably may be P34 protein and its homologous protein, but is not limited thereto.
[0026] In a method for producing a genome-edited soybean plant with reduced allergens according to one embodiment of the present invention, the soybean-derived GmP34, GmP34h1, and GmP34h2 genes may preferably each consist of the nucleotide sequences of SEQ ID NO. 1, SEQ ID NO. 2, and SEQ ID NO. 3, but are not limited thereto.
[0027] In addition, in a method for producing a genome-edited soybean plant with reduced allergens according to one embodiment of the present invention, the target nucleotide sequences of the GmP34, GmP34h1, and GmP34h2 genes may consist of the nucleotide sequences of SEQ ID NO. 4 and SEQ ID NO. 5, but are not limited thereto. The nucleotide sequences of SEQ ID NO. 4 and SEQ ID NO. 5 are characterized by targeting all of the GmP34, GmP34h1, and GmP34h2 genes.
[0028] The term "genome / gene editing" refers to a technology capable of introducing targeted mutations into the genomic sequences of animal and plant cells, including human cells, and involves knocking out or knocking in specific genes by the deletion, insertion, or substitution of one or more nucleic acid molecules through DNA cutting, or introducing mutations into non-coding DNA sequences that do not produce proteins. For the purposes of the present invention, the genome editing may specifically involve introducing mutations into a plant using an endonuclease, such as the Cas9 protein, and a guide RNA.
[0029] The term "target gene" refers to a portion of DNA within the genome of a plant to be corrected through the present invention. That is, in principle, it is not limited to the type of gene and may include both coding and non-coding regions. A person skilled in the art may select the target gene according to the desired variation in the genome-edited plant to be manufactured, depending on the purpose.
[0030] The term "guide RNA" refers to RNA specific to DNA that encodes the base sequence of a target gene, and refers to a ribonucleic acid that binds wholly or partially complementarily to the target DNA base sequence to guide an endonuclease protein to the corresponding target DNA base sequence. The guide RNA refers to a dual RNA comprising two RNAs, namely crRNA (CRISPR RNA) and tracrRNA (trans-activating crRNA), as components; or a single-stranded guide RNA (sgRNA) form comprising a first region containing a sequence wholly or partially complementary to the base sequence within the target DNA and a second region containing a sequence that interacts with the RNA-guide nuclease; however, any form capable of having activity at the target base sequence may be included within the scope of the present invention without limitation. The guide RNA according to the present invention may preferably be in the form of a single-stranded guide RNA, but is not limited thereto, and may be appropriately selected according to known techniques in the art regarding the type of endonuclease used or the microorganism from which the endonuclease originates.
[0031] Additionally, the guide RNA may be transcribed from a plasmid template or transcribed in vitro (e.g., an oligonucleotide double strand), but is not limited thereto.
[0032] In addition, in a manufacturing method according to one embodiment of the present invention, introducing the guide RNA and endonuclease protein of step (a) into a soybean plant cell may utilize, but is not limited to: a recombinant vector comprising a DNA sequence encoding a guide RNA specific to the target base sequence of soybean-derived GmP34, GmP34h1, and GmP34h2 genes and a nucleic acid sequence encoding an endonuclease protein; or a complex of a guide RNA specific to the target base sequence of soybean-derived GmP34, GmP34h1, and GmP34h2 genes and an endonuclease protein.
[0033] In a manufacturing method according to one embodiment of the present invention, the endonuclease protein may be one or more selected from the group consisting of Cas9 (CRISPR associated protein 9), Cpf1 (CRISPR from Prevotella and Francisella 1), TALEN (Transcription activator-like effector nuclease), ZFN (Zinc Finger Nuclease), or functional analogs thereof, and preferably may be a Cas9 protein, but is not limited thereto.
[0034] Cas9 protein or genetic information can be obtained from known databases such as GenBank of the NCBI (National Center for Biotechnology Information). For example, the Cas9 protein may be one or more selected from the group consisting of Cas9 proteins derived from Streptococcus pyogenes, Cas9 proteins derived from Campylobacter jejuni, Cas9 proteins derived from Streptococcus thermophilus or Streptococcus aureus, Cas9 proteins derived from Neisseria meningitidis, Cas9 proteins derived from Pasteurella multocida, Cas9 proteins derived from Francisella novicida, but is not limited thereto.
[0035] The Cas9 protein is an RNA-guided DNA endonuclease enzyme that induces double-stranded DNA breaks. For the Cas9 protein to accurately bind to the base sequence of the target DNA and cut the DNA strand, a short base sequence consisting of three bases known as PAM (Protospacer Adjacent Motif) must be present next to the base sequence of the target DNA, and the Cas9 protein cuts by estimating the interval between the 3rd and 4th base pairs from the PAM sequence (NGG).
[0036] In a manufacturing method according to one embodiment of the present invention, the guide RNA and the endonuclease protein form a ribonucleoprotein complex and function as an RNA-Guided Engineered Nuclease (RGEN).
[0037] The CRISPR / Cas9 system used in the present invention is a gene correction method based on the NHEJ (non-homologous end joining) mechanism, which induces insertion-deletion (InDel) mutations caused by incomplete repair induced during the DNA repair process by introducing a double helix cut at a specific location of a specific gene to be corrected.
[0038] In the manufacturing method according to the present invention, the method of transfecting the complex of the guide RNA and the endonuclease protein into a plant cell comprises the calcium / polyethylene glycol method for protoplasts (Krens et al., 1982, Nature 296: 72-74; Negrutiu et al., 1987, Plant Mol. Biol. 8: 363-373), the electroporation method for protoplasts (Shillito et al., 1985, Bio / Technol. 3: 1099-1102), the microinjection method into plant elements (Crossway et al., 1986, Mol. Gen. Genet. 202: 179-185), the particle impact method for various plant elements (DNA or RNA-coated) (Klein et al., 1987, Nature 327: 70), and Agrobacterium tumefaciens. It can be appropriately selected from tumefaciens-mediated gene transfer (incompleteness) and infection by a virus (EP 0 301 316), etc.
[0039] In addition, introducing the recombinant vector into a plant cell constitutes a transformation method. Transformation of plant species is now common for plant species including both dicotyledonous and monocotyledonous plants. In principle, any transformation method can be used to introduce the recombinant vector according to the present invention into a suitable progenitor cell.
[0040] The “plant cell” used for the above-mentioned modification may be any plant cell. The plant cell is a cultured cell, cultured tissue, cultured organ, or whole plant. The “plant tissue” includes differentiated or undifferentiated plant tissues, such as, but not limited to, roots, stems, leaves, pollen, seeds, female tissue, and various forms of cells used for culture, namely single cells, protoplasts, shoots, and callus tissue. The plant tissue may be in planta or in organ culture, tissue culture, or cell culture.
[0041] In the manufacturing method of the present invention, any method known in the art may be used for redifferentiating a genome-corrected plant from a genome-corrected plant cell. The genome-corrected plant cell must be redifferentiated into a whole plant. Techniques for redifferentiating mature plants from callus or protoplast cultures are known in the art for numerous different species.
[0042] The present invention also provides a genome-edited soybean plant with reduced allergens produced by the above-described manufacturing method and seeds of said plant.
[0043] The genome-edited soybean plant with reduced allergens according to the present invention is a soybean plant in which the GmP34, GmP34h1, and GmP34h2 genes are edited using the CRISPR / Cas9 system, and the soybean-derived GmP34, GmP34h1, and GmP34h2 genes are knocked out, resulting in a soybean plant with reduced allergens compared to a soybean plant without genome editing.
[0044] The present invention also provides a genome editing composition for reducing allergens in soybean plants, comprising as an active ingredient a recombinant vector comprising DNA encoding a guide RNA specific to the target nucleotide sequences of soybean-derived GmP34, GmP34h1, and GmP34h2 genes and a nucleic acid sequence encoding an endonuclease protein; or a complex of a guide RNA specific to the target nucleotide sequences of soybean-derived GmP34, GmP34h1, and GmP34h2 genes and an endonuclease protein.
[0045] In the genome editing composition of the present invention, the target nucleotide sequences of the GmP34, GmP34h1, and GmP34h2 genes may be composed of the nucleotide sequences of SEQ ID NO. 4 and SEQ ID NO. 5, but are not limited thereto.
[0046] The genome editing composition of the present invention comprises a recombinant vector comprising DNA encoding a guide RNA specific to the target base sequences of the GmP34, GmP34h1, and GmP34h2 genes and a nucleic acid sequence encoding an endonuclease protein, or a complex of a guide RNA specific to the target base sequences of the GmP34, GmP34h1, and GmP34h2 genes and an endonuclease protein, wherein when the composition is applied to soybean plant cells, the complex of the guide RNA and the endonuclease protein acts as an RNA gene scissors to edit the target genes.
[0047] The genome editing composition of the present invention preferably includes a guide RNA specific to the target nucleotide sequences of the GmP34, GmP34h1, and GmP34h2 genes, which are composed of the nucleotide sequences of SEQ ID NO. 4 and SEQ ID NO. 5, so that the GmP34, GmP34h1, and GmP34h2 genes can be knocked out, and allergens in soybean plants can be reduced through the knockout of the GmP34, GmP34h1, and GmP34h2 genes.
[0048]
[0049] The present invention will be explained in detail below through examples. However, the following examples are merely illustrative of the present invention, and the scope of the present invention is not limited to the following examples.
[0050]
[0051] Materials and Methods
[0052] 1. Plant materials
[0053] Seeds of the soybean (Glycine max) variety Williams 82 were washed under running water for 30 minutes, selected for their normal seed coats, sterilized in 70% (v / v) ethanol for 30 seconds, sterilized in a 1% (v / v) sodium hypochlorite solution for 30 minutes, washed, and then dried to remove excess water. Subsequently, the seeds were placed on a germination medium (B5 medium 3.2 g, sucrose 20 g, MES 0.5 g, agar 8 g, pH 5.7) with the hilum facing downward, and germinated in a 26°C incubator under dark conditions for 20 hours. Afterward, they were grown in a greenhouse under long-term conditions (16 hours light, 8 hours dark).
[0054]
[0055] 2. Vector construction for transformation and soybean transformation
[0056] In order to perform sperm editing targeting the soybean-derived GmP34 (Glyma08g116300) gene and its homologs, GmP34h1 (Glyma08g116400) and GmP34h2 (Glyma05g158600) genes simultaneously, gRNA1 and gRNA3 that specifically bind to target sequences within the first exons of the GmP34, GmP34h1, and GmP34h2 genes were designed using the CRISPRdirect web tool (Fig. 1), and the pMDC123_pcoCas9_CRISPR_P34 vector was prepared by inserting gRNA1 and gRNA3 into the pMDC123 vector containing the plant codon-optimized Cas9 gene via golden gate cloning (Fig. 2). Subsequently, soybean seeds germinated in a germination medium for 20 hours were split in half using a blade and co-cultured for 4 days with the Agrobacterium tumefaciens EHA105 strain containing the aforementioned pMDC123_pcoCas9_CRISPR_P34 vector. After inoculating onto SEMP5 medium (per 1 L: MS B5 medium 4.4 g, sucrose 30 g, sodium thiosulfate 158 mg, DTT 154 mg, MES 0.6 g, asparagine 50 mg, pyroglutamic acid 100 mg, agar 8 g, zeatin 1 mg, GA3 1 mg, IAA 0.1 mg, cefotaxim 125 mg, thimetin 50 mg, vancomycin 50 mg), the seeds were subcultured, and when the stems elongated to more than 4 cm, the stem portions were cut. Roots were induced in an antibiotic-free root induction medium (per 1 L: MS B5 medium 4.4 g, sucrose 30 g, sodium thiosulfate 158 mg, DTT 154 mg, MES 0.6 g, asparagine 50 mg, pyroglutamic acid 100 mg, agar 8 g, IBA 1 mg, cefotaxim 50 mg, thimetin 50 mg, vancomycin 25 mg).Afterwards, the transgenic plants that developed roots from the cut surface of the stem were transferred to small pots, acclimatized in plastic containers for two weeks, then transferred to large pots and grown in a greenhouse.
[0057]
[0058] Example 1. Preparation of soybean transformants with GmP34, GmP34h1, and GmP34h2 genes edited
[0059] Transformers (T0) with induced GmP34, GmP34h1, and GmP34h2 gene editing were produced by co-culturing a strain of Agrobacterium tumopaciens containing a pMDC123_pcoCas9_CRISPR_P34 vector prepared to express gRNA1 and gRNA3 (Table 1) that simultaneously target soybean-derived GmP34, GmP34h1, and GmP34h2 genes with soybean seeds.
[0060] GmP34 , GmP34h1 and GmP34h2 gRNA Information Classification gRNA Target Sequence (5'-3') Sequence Number gRNA1ACTAGAAGAGAGACCTAAGA4gRNA3TGAAGACACCTGTTTCTGTG5
[0061] Subsequently, genomic DNA was extracted from each of the above transformants, and PCR was performed on the selection marker genes, Bar and Cas9, within the vector to confirm whether T-DNA was introduced. Additionally, Indel (Insertion / Deletion) PCR was performed on the GmP34, GmP34h1, and GmP34h2 genes to confirm whether the GmP34, GmP34h1, and GmP34h2 genes were edited. As a result, a T0 transformant (#1) with the GmP34 gene edited and a T0 transformant (#14) with the GmP34h1 gene edited were selected (Fig. 3). Subsequently, genomic DNA was extracted from the selected T0 transformants (#1, #14), and sequencing analysis was performed on the GmP34, GmP34h1, and GmP34h2 genes.
[0062] As a result, it was confirmed that some bases were deleted or substituted in various patterns in the GmP34, GmP34h1, and GmP34h2 genes of T0 transformants (#1, #14) (Fig. 4).
[0063] In addition, seeds were obtained by advancing the generations of the above T0 transformants (#1, #14) and culturing them in a greenhouse to obtain T1 transformants. Proteins were extracted from each individual of the above T1 transformants, and Western blot analysis was performed for P34 protein.
[0064] As a result, T1 transformants (#1-#32, #1-#48, #1-#55, #1-#65, #1-#72, #14-#76, #14-#77, #14-#78, #14-#80, #14-#99, #14-#101, #14-#105, #14-#109, #14-#110, #14-#114, #14-#115, #14-#117, #14-#120, #14-#121, #14-#128, #14-#129) in which the allergen P34 protein is not expressed were obtained (Fig. 5).
[0065]
[0066] Example 2. Analysis of gene editing efficiency of gRNA1 and gRNA3
[0067] Among the GmP34, GmP34h1, and GmP34h2 gene-edited T1 transformants according to the present invention, 18 lines (#1-#32, #1-#48, #1-#55, #1-#65, #1-#72, #14-#76, #14-#77, #14-#78, #14-#80, #14-#99, #14-#101, #14-#105, #14-#109, #14-#114, #14-#115, #14-#117, #14-#120, #14-#129) were selected, genomic DNA was extracted from each transformant, and PCR was performed on the marker genes Bar and Cas9 genes, and for the GmP34, GmP34h1, and GmP34h2 genes Indel PCR was performed.
[0068] If a band smaller than the control group (wild-type soybean plant) was observed, it was determined to be 100% homozygote, and if a band of the same size as the control group and a band smaller than that were observed together, it was determined to be heterozygote.
[0069] As a result, among the GmP34, GmP34h1, and GmP34h2 gene-edited T1 transformants, 100% gene-edited homozygote was confirmed in line #1 for the GmP34 gene and 100% gene-edited homozygote was confirmed in line #14 for the GmP34h1 gene (Fig. 6).
[0070] Through the above results, it was found that using gRNA1 and gRNA3, which simultaneously target the GmP34, GmP34h1, and GmP34h2 genes according to the present invention, 100% gene-edited soybean lines can be secured in the T1 generation.
[0071] In addition, deep sequencing results confirmed that gene editing was performed in individuals #1-65 with a 61bp deletion and a 1bp substitution in the GmP34 gene and a 1bp deletion in the GmP34h1 gene, and in individuals #14-114 and #14-117 with a 4bp deletion in the GmP34 gene, a 75bp deletion in GmP34h1, and an 8bp deletion in GmP34h2 (Fig. 7).
[0072] Based on the above results, it was found that the present invention secured a gene-edited soybean line without the external gene T-DNA.
[0073]
[0074] Example 3. Comparison of gene editing efficiencies of gRNA1 and gRNA2
[0075] The aim was to demonstrate that the gene editing efficiency of gRNA1 and gRNA3, which simultaneously target the GmP34, GmP34h1, and GmP34h2 genes according to the present invention, is superior to that of other gRNAs. Specifically, 20 lines (#10-#11 to #10-#30) were selected from T3 transformants prepared using gRNA1 and gRNA2 (Table 2, Fig. 8A) which simultaneously target the GmP34 and GmP34h1 genes (refer to Korean Registered Patent No. 2574819). Genomic DNA was extracted from each transformant, and PCR was performed on the marker genes Bar and Cas9, and Indel PCR was performed on the GmP34 and GmP34h1 genes.
[0076] GmP34 and GmP34h1 gRNA information targeting genes Classification gRNA Sequence (5'-3') Sequence Number gRNA1ACTAGAAGAGAGACCTAAGA4gRNA2GCCCCCTTGGTACTTTACTT6
[0077] As a result, the GmP34 and GmP34h1 gene-edited T3 transformants confirmed 100% gene-edited homozygotes in the GmP34 and GmP34h1 genes (Fig. 8B). On the other hand, the GmP34 and GmP34h1 gene-edited T1 transformants were found to be unable to secure 100% gene-edited homozygotes in the GmP34 and GmP34h1 genes (Fig. 9).
[0078] Based on the above results, using gRNA1 and gRNA3 targeting the GmP34, GmP34h1, and GmP34h2 genes according to the present invention shortens the time to secure soybean transformants compared to using gRNA1 and gRNA2 targeting the GmP34 and GmP34h1 genes (T3 generation → It was possible to make the T1 generation)
Claims
1. (a) a step of correcting the genome by introducing guide RNA and endonuclease proteins specific to the target nucleotide sequences of soybean-derived GmP34, GmP34h1, and GmP34h2 genes into soybean plant cells; and (b) a step of redifferentiating a soybean plant from a soybean plant cell with the above-mentioned genome corrected; a method for producing a genome-edited soybean plant with reduced allergens, comprising: (b) a step of redifferentiating a soybean plant from a soybean plant cell with the above-mentioned genome corrected.
2. A method for producing a genome-edited soybean plant with reduced allergens, characterized in that, in claim 1, the target nucleotide sequences of the GmP34, GmP34h1, and GmP34h2 genes consist of the nucleotide sequences of SEQ ID NO. 4 and SEQ ID NO.
5.
3. A method for producing a genome-edited soybean plant with reduced allergens, wherein, in claim 1, introducing the guide RNA and endonuclease protein of step (a) into a soybean plant cell, the method comprises using a recombinant vector comprising a DNA sequence encoding a guide RNA specific to the target base sequence of soybean-derived GmP34, GmP34h1, and GmP34h2 genes and a nucleic acid sequence encoding an endonuclease protein; or a complex of a guide RNA specific to the target base sequence of soybean-derived GmP34, GmP34h1, and GmP34h2 genes and an endonuclease protein.
4. A genome-edited soybean plant with reduced allergens produced by the method of any one of paragraphs 1 to 3.
5. Seeds in which the genome of a soybean plant has been corrected pursuant to Paragraph 4.
6. A genome editing composition for reducing allergens in soybean plants, comprising as an active ingredient a recombinant vector comprising DNA encoding a guide RNA specific to the target base sequences of soybean-derived GmP34, GmP34h1, and GmP34h2 genes and a nucleic acid sequence encoding an endonuclease protein; or a complex of a guide RNA specific to the target base sequences of soybean-derived GmP34, GmP34h1, and GmP34h2 genes and an endonuclease protein.
7. A genome editing composition for reducing allergens in soybean plants, characterized in that, in claim 6, the target nucleotide sequences of the GmP34, GmP34h1, and GmP34h2 genes consist of the nucleotide sequences of SEQ ID NO. 4 and SEQ ID NO. 5.
